Are there echos from the early Wright shareholder lawsuits?
Have post-Covid earnings devalued the deal?
Is Stryker having trouble satisfying HSR?
Is Stryker distracted by a new multi-$B deal?
Are a large portion of Wright shareholders reluctant to sell at $30.75 per share?
Read more here - Everything you need to know about the Stryker-Wright acquisition
Stryker extends its bid for Wright Medical — again (MassDevice)
Stryker (NYSE:SYK) announced today that it extended the offering period of its cash tender offer for all shares of Wright Medical (NSDQ:WMGI).
Kalamazoo, Mich.-b...
